3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
110
Sarcoma
58
Lymphoid
9
Gynecologic
3
Genitourinary
3
Gastrointestinal
2
Dermatologic
2
Thoracic
1
Other solid neoplasm
1
Other hematologic neoplasm
1
Head & Neck
1
Endocrine
1
Classical hematology
1
Breast
1
Conditions
Breast Neoplasms
14
Brain Neoplasms
6
Ovarian Neoplasms
4
Melanoma
4
Triple Negative Breast Neoplasms
3
Neoplasm Metastasis
3
Sarcoma
2
Prostatic Neoplasms
2
Neoplasms, Second Primary
2
Fallopian Tube Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Stomach Neoplasms
1
Small Cell Lung Carcinoma
1
Pancreatic Neoplasms
1
Lung Neoplasms
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Head and Neck Neoplasms
1
Glioma
1
Glioblastoma
1
Esophageal Neoplasms
1
Central Nervous System Neoplasms
1
Carcinoma, Hepatocellular
1
Breast Neoplasms, Male
1
Astrocytoma
1
Interventions
selpercatinib
2
Trastuzumab
2
Paclitaxel
2
sodium thiosulfate
1
pazopanib
1
glutathione pegylated liposomal doxorubicin
1
fluoroacetic acid
1
elacestrant
1
durvalumab
1
carboxyamido-triazole
1
abemaciclib
1
Temozolomide
1
Taxes
1
Surveys and Questionnaires
1
RAD1901
1
Quality of Life
1
Patient Reported Outcome Measures
1
Molecular Diagnostic Techniques
1
Methotrexate
1
Magnetic Resonance Spectroscopy
1
MLN 8237
1
Levofloxacin
1
Lapatinib
1
Immunotherapy
1
Immunoenzyme Techniques
1
Genetic Testing
1
Genetic Counseling
1
Gemcitabine
1
Drug Therapy
1
D-methadone
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Central Nervous System Neoplasms
×
Temozolomide
×
Breast
×
Clear all
NCT00629187
2012-04-27
CN-306
Tufts Medical Center
Phase 1
Terminated
2 enrolled